News
GlobalData on MSN19h
BioAtla presents Phase I data of BA3182 for metastatic adenocarcinomaBioAtla has presented first-in-human Phase I study data of its anti-cancer therapy, BA3182, targeting those with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback